A new role of ‘Gender Medicine’ GP is to be established, the NHS has announced.
Adopting the recommendation from Dr David Levy’s recent review of Adult Gender Clinics, the NHS claimed gender GPs would help “improve productivity” and allow gender-confused adults to be discharged into their care from specialist clinics more quickly.
Last year, researchers reported that women who undergo trans-affirming hormone therapy are likely to suffer from incontinence and constipation.
‘Gross failings’
In a letter to Dr Levy welcoming his report, the NHS committed to a “system-wide response” to gender-affirming care for over-18s, including “working with professional bodies to establish a new professional role of GP with an Extended Role in Gender Medicine”.
But Sex Matters CEO Maya Forstater expressed astonishment that while Levy’s review catalogued “the many gross failings of adult gender clinics”, he had recommended “the process of assessment and treatment be standardised and accelerated”.
She called the proposal “a wasted opportunity to rethink a failed treatment model”.
Harms
In a Brazilian study published in April 2024, nine out of ten women who took testosterone to ‘transition’ from female to male suffered from Pelvic Floor Dysfunction (PFD), a condition which affects bowel and bladder function.
Using an online questionnaire, 68 women who had taken the sex-swap hormone were assessed for symptoms of PFD.
Urinary symptoms, such as bed wetting, affected 87 per cent of participants; nearly three quarters of respondents said they suffered from bowel problems, including constipation and flatulence; and over a half of those questioned also reported some sort of sexual dysfunction.
Shocking admissions of the harmful effects of ‘trans-affirming care’ also emerged last year in leaked files from the World Professional Association for Transgender Health.
NHS nurseries blasted for ‘indoctrinating’ toddlers with LGBT ideology
NHS hospital criticised for advising staff against saying people are ‘born male or female’